Do Peptides Show Up on a Drug Test? WADA, USADA and the Workplace

Do peptides show up on a drug test? How WADA and USADA treat them under S0 and S2, and why a workplace or DOT panel asks a different, mostly unverified question.

Written bySebastian Hunter, Founder and EditorI'm a 42-year-old senior advisor and distance runner who came to peptides as a sceptic. I'm not a doctor: I read the research, run my own experiment and keep honest notes. Read full bio

Published September 24, 2026Updated September 30, 2026

The short version

Competing athletes and ordinary employees face two different testing questions that get mixed together online. Sport anti-doping is a defined system: the World Anti-Doping Agency publishes an exact list, and named peptides sit in categories S0 and S2, banned at all times. Workplace drug testing is far less defined. Standard employer panels are not built to catch peptides, and I could not verify much about that side.

WADA bans specific peptides by name under S0 (non-approved substances) and S2 (peptide hormones, growth factors and mimetics), at all times, in and out of competition.
Sport anti-doping testing and employer drug screening are separate systems with separate rules. One does not imply the other.
Standard workplace drug panels target illicit drugs, not research peptides, and I could not verify a general practice of employers testing for peptides.
A vial labelled "research use only" is no defence against a WADA violation. Strict liability applies to whatever is in an athlete's system.

“Do peptides show up on a drug test?” gets asked in two different contexts, and the answers do not transfer between them. A competing athlete is under a published, specific rulebook. An employee taking a workplace screen is not. This page keeps the two questions separate, unlike most forum posts.

Sport anti-doping: a defined list, not a guess

Athletes bound by the World Anti-Doping Code are tested against the WADA Prohibited List, updated at least annually and in force on a fixed date. It names specific substances and classes in numbered categories. Two of those categories are where research peptides live.

S0 - Non-Approved Substances

S0 is a catch-all for anything with no current approval from any government health regulator for human therapeutic use. That covers drugs still in preclinical or clinical development, discontinued drugs, designer drugs, and substances approved only for veterinary use. Every substance in this class is prohibited at all times, in and out of competition.

WADA’s own text for S0 names BPC-157 explicitly as an example, alongside unrelated compounds such as 2,4-dinitrophenol. See the BPC-157 compound page for what is and is not established about it outside sport.

“Unapproved for human use” and “sold as a research chemical” describe the same fact. No regulator has said the substance is safe or effective for people, so WADA treats it as prohibited by default instead of waiting to ban it individually.

S2 is the dedicated peptide category, also prohibited at all times. Unlike S0, every substance here is a non-specified substance, which affects sanctioning rather than whether it is banned. WADA splits S2 into numbered subsections. The two that cover most peptides sold to consumers are S2.2 and S2.3.

S2.2 - peptide hormones and their releasing factors

This subsection names, among others:

Growth hormone-releasing hormone (GHRH) and its analogues - the list gives CJC-1293, CJC-1295, sermorelin and tesamorelin as examples.
Growth hormone secretagogues (GHS) and their mimetics - including ibutamoren (MK-677) and ipamorelin, among others named on the list.
Growth-hormone-releasing peptides (GHRPs) - including examorelin (hexarelin), GHRP-2 (pralmorelin) and GHRP-6, among the numbered GHRP series the list names.
Growth hormone analogues and fragments - including the fragment AOD-9604.

Compound pages for named examples: CJC-1295, sermorelin, tesamorelin, ipamorelin, MK-677, hexarelin, GHRP-2, GHRP-6, AOD-9604.

S2.3 - growth factors and growth factor modulators

This subsection names:

fibroblast growth factors
hepatocyte growth factor
IGF-1
mechano growth factors
platelet-derived growth factor
vascular endothelial growth factor
thymosin-β4 and its derivatives, giving TB-500 as the named example

See TB-500 and the BPC-157 vs TB-500 comparison for how that one is commonly confused with the unrelated full-length protein.

peg-MGF falls under the same mechano-growth-factor language, as a modified fragment of the class the list names.

What USADA tells US athletes

USADA, the US national anti-doping organisation, publishes plain-language guidance that tracks the WADA categories above. It makes three points directly:

Its explainer on peptide hormones and releasing factors says the S2.2 prohibition covers peptide hormones “with anabolic or strength enhancing actions” and applies at all times. It adds that even an unlisted substance can be treated as banned if it has a similar chemical structure or biological effect to a listed one.
Its article on BPC-157 confirms the S0 classification. It says a therapeutic use exemption for it is unlikely to be approved, because approved alternatives exist for most of the uses people ask about. Each application is still reviewed individually.
Its guidance on peptides and growth factors in cosmetics says topical use of a prohibited growth factor or peptide is just as prohibited as an injectable or oral form. Route does not change S2 status, so a “cosmetic” cream naming fibroblast growth factor, IGF-1, VEGF or PDGF carries the same risk as an injection.

USADA directs athletes with a product question to check status on GlobalDRO.com and to contact its Drug Reference Line before using anything they are unsure about. Do not guess from a label or a forum thread.

Workplace drug testing is a different question

Everything above is about sport, governed by a published Code, a published list and a named regulator. A workplace drug test runs under none of that. It is set by an individual employer, an industry regulator, or (in some safety-sensitive roles) a government transport or occupational rule. None of those bodies publishes anything like the WADA Prohibited List for peptides.

What I can say with reasonable confidence, and what I cannot verify:

Standard occupational panels target a fixed, different list. The common five- or ten-panel workplace tests are built around illicit drugs of abuse: cannabinoids, cocaine, opiates, amphetamines and PCP. They use antibody-based immunoassay screening designed for those molecules. Detecting a peptide is a different analytical problem and typically needs targeted mass-spectrometry methods.
I could not verify how common peptide testing is in employment settings. Whether an employer, insurer or safety-sensitive occupational programme screens for peptides is that organisation’s policy decision. I found no general, publicly documented practice of standard workplace panels including peptide hormones or growth factors. That is a gap in what I found, not proof it never happens.
A prescription changes the picture, but through your employer or clinician. Approved medicines such as prescription growth hormone or GLP-1 products are legitimately used under medical supervision. An employer’s policy on prescribed medication is a question for that employer’s HR or occupational health function.

Your job may require you to know whether a substance would appear on an employer’s test. Examples are a safety-sensitive role, a professional licence or a specific company policy. In that case, ask the employer, the relevant occupational health provider or an employment lawyer.

DOT-regulated and military testing

Some testing that looks like “workplace policy” is federal regulation, with a published panel rather than a private employer decision.

DOT-regulated safety-sensitive roles

Commercial drivers, pilots, rail and transit workers and other federally regulated safety-sensitive transportation employees in the US are tested under the Department of Transportation’s drug-testing rule, 49 CFR 40.85. It sets an exact panel with fixed cutoff concentrations:

marijuana metabolites
cocaine metabolite
opioids (codeine/morphine, hydrocodone/hydromorphone, oxycodone/oxymorphone, 6-acetylmorphine)
phencyclidine (PCP)
amphetamines (amphetamine/methamphetamine, MDMA/MDA)

No peptide is named anywhere in that panel.

Military testing

I could not verify the specific substances tested for in US military or other national armed-forces drug-testing programmes. Military regulation sets that panel, not DOT or WADA rules, and none of the government sources this page draws on publish it. A service member with a specific question should ask their own command or medical unit.

Common questions

Are all peptides banned in sport?

No. The WADA Prohibited List names specific peptides and peptide classes, mainly under S0 and S2. Many peptides sold as research chemicals are not named on the list at all. That does not make them safe or approved. It only means WADA has not classed that substance as prohibited.

What is the difference between S0 and S2 on the WADA list?

S0 covers non-approved substances generally: anything with no current approval from any government health regulator for human therapeutic use, named case by case, including BPC-157. S2 is the category for peptide hormones, growth factors, related substances and mimetics. It has numbered subsections for things such as growth-hormone-releasing peptides and growth factors.

Does a "research use only" label protect an athlete from a positive test?

No. WADA operates under strict liability. An athlete is responsible for whatever prohibited substance is found in their sample, however it was labelled, sold or obtained. A research-only sticker changes nothing about anti-doping rules.

Do employers test for peptides in a standard workplace drug test?

I could not verify a general practice of this. Standard occupational panels are built around illicit drugs, not research peptides, and peptide detection needs more specialised laboratory methods. Whether a specific employer or industry tests for peptides depends on that employer's own policy.

Will BPC-157 make you fail a drug test?

For a competing athlete, yes. BPC-157 sits under S0 on the WADA Prohibited List and is banned at all times, so a positive test is a doping violation regardless of intent. For a standard workplace screen, I could not verify that it would. Those panels target illicit drugs of abuse, not research peptides, and I found no documented general practice of employers testing for BPC-157 specifically.

Can police officers take peptides?

A specific police department's employment policy is a question for that department. On testing, the same logic as other safety-sensitive employers applies. The federal DOT panel used for safety-sensitive transportation roles targets illicit drugs of abuse, not research peptides. I could not verify whether any given police department tests beyond a standard panel.

Is a peptide a steroid?

No. A peptide is a short chain of amino acids. A steroid is a chemically different class of molecule, built on a cholesterol-derived ring structure. They are not two names for the same thing.

What peptides are legal now?

There is no single answer. Legal status depends on the compound, the country and whether it has any government-approved medical use, and it changes over time. A few peptides, such as semaglutide and tirzepatide, are approved prescription medicines in some countries. Most peptides sold as research chemicals have no such approval anywhere. See my guide to the legal status of research peptides for how that is assessed compound by compound.

What shows up on a 12-panel drug test?

The exact contents vary with the laboratory and the employer ordering it, so I cannot list them for a given test. Like the common five- and ten-panel tests, workplace panels screen for drugs of abuse. I found no standard panel that includes peptides, which typically need targeted mass-spectrometry methods to detect. The one federally defined panel I cite, DOT's 49 CFR 40.85, names no peptide.

References (5 sources)

Bibliographic detail is fetched from PubMed, not written by me - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than my judgement.

1.WADA Prohibited List - live category browser, showing the current S0 (Non-Approved Substances) and S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics) entries in force.- World Anti-Doping Agencyregulatory
2.USADA - 6 Things to Know About Peptide Hormones and Releasing Factors, covering the S2.2 category and therapeutic use exemption guidance.- US Anti-Doping Agencyregulatory
3.USADA - BPC-157: Experimental Peptide Creates Risk for Athletes, confirming BPC-157's S0 status and TUE outlook.- US Anti-Doping Agencyregulatory
4.USADA - Peptides and Growth Factors in Cosmetics, on topical products and S2 substances applying regardless of route of administration.- US Anti-Doping Agencyregulatory
5.eCFR - 49 CFR 40.85, the US DOT drug-testing rule setting the exact panel and cutoff concentrations for safety-sensitive transportation employees.- US Government, Electronic Code of Federal Regulationsregulatory